Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of 0.02 is 29% above its 1-year average of 0.01, around the middle of its 1-year range (0.00–0.04).
As of the fiscal period ended Friday, July 31, 2026. 9.33% above its 12-month average of 0.01.
Reported quarterly debt to equity ratio; no daily interpolation. Q1 FY2026 (2026-07-31): 0.02.
DEBT TO EQUITY RATIO
0.02
DEBT TO EQUITY RATIO AVG TTM
0.01
DEBT TO EQUITY RATIO AVG 3Y
N/A
DEBT TO EQUITY RATIO AVG 5Y
N/A
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+9.33%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11
median of 774 covered companies
CURRENT VS SECTOR MEDIAN
-85.18%
vs the sector median at left
MiniMed Group, Inc. Common Stock
Market Cap
$5.52B
Debt to Equity Ratio
0.02
TTM Avg
0.01
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.32B
Debt to Equity Ratio
N/A
TTM Avg
441.80
3Y Avg
221.15
5Y Avg
147.72
Market Cap
$5.78B
Debt to Equity Ratio
1.57
TTM Avg
0.74
3Y Avg
0.65
5Y Avg
0.49
Market Cap
$5.79B
Debt to Equity Ratio
0.06
TTM Avg
0.08
3Y Avg
0.11
5Y Avg
0.11
Market Cap
$5.21B
Debt to Equity Ratio
0.45
TTM Avg
0.16
3Y Avg
0.15
5Y Avg
0.12
Market Cap
$5.21B
Debt to Equity Ratio
25.16
TTM Avg
4.83
3Y Avg
5.30
5Y Avg
3.87
Market Cap
$5.20B
Debt to Equity Ratio
3.41
TTM Avg
4.78
3Y Avg
5.15
5Y Avg
4.66
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiniMed Group, Inc. Common Stock (MMED) | $5.52B | 0.02 | 0.01 | N/A | N/A |
| RadNet, Inc. (RDNT)vs › | $5.53B | 1.99 | 1.81 | 2.63 | 3.97 |
| CG Oncology Inc. (CGON)vs › | $5.61B | 0.01 | 0.01 | 0.04 | 0.11 |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.32B | N/A | 441.80 | 221.15 | 147.72 |
| Kodiak Sciences Inc. (KOD)vs › | $5.78B | 1.57 | 0.74 | 0.65 | 0.49 |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.79B | 0.06 | 0.08 | 0.11 | 0.11 |
| CRISPR Therapeutics AG (CRSP)vs › | $5.21B | 0.45 | 0.16 | 0.15 | 0.12 |
| Travere Therapeutics, Inc. (TVTX)vs › | $5.21B | 25.16 | 4.83 | 5.30 | 3.87 |
| Sotera Health Company (SHC)vs › | $5.20B | 3.41 | 4.78 | 5.15 | 4.66 |
| Doximity, Inc. (DOCS)vs › | $5.20B | 0.01 | 0.01 | 0.02 | 0.01 |
Debt/Equity
0.02
Current Ratio
1.81
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-07-31 | 0.02 |
| 2026-04-24 | 0.04 |
| 2026-01-31 | 0.00 |
| 2025-10-31 | 0.00 |
| 2025-04-30 | 0.00 |
